about
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differ...
Read More59,535 XNAS Volume
XNAS 05 May, 2025 2:34 PM (EDT)
Board Meeting
The next board meeting for Celcuity Inc is on 15 May 2025 for the purpose of Celcuity Inc First Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Celcuity Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..